Share this post on:

Name:

Vatelizumab Biosimilar, Anti-CD49b/ITGA2

Host species:

Humanized

Species reactivity:

Human

Form:

solution

Storage buffer:

0.01M PBS, pH 7.4.

Concentration:

1 mg/ml

Purity:

>95%.category:Monoclonal

Isotype:

IgG4-kappa

Applications:

Biosimilar

For research use only. We do not sell to patients.

Target:

Collagen receptor, ITGA2, VLA-2 subunit alpha, CD49B, CD49 antigen-like family member B, Platelet membrane glycoprotein Ia, GPIa, Integrin alpha-2, CD49b

Purification:

Protein A/G purified from cell culture supernatant.

Endotoxin level:

Please contact with the lab for this information.

Expression system:

MammalianP17301https://www.ncbi.nlm.nih.gov/protein/P17301

Stability and Storage:

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4C short term

1-2 weeks:

.Store at -20 C 12 months. Store at -80C long term.

Alternative Names:

GBR500, CAS: 1238217-55-4Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
BTK Antibody (YA816)
Cy7-conjugated AffiniPure Goat Anti-Rabbit IgG H&L
CD9 Antibody: CD9 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 25 kDa, targeting to CD9. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: signsin1dayinc